Private practice with Dr Seth BilazarianView all posts »
Learning from AIM-HIGHMay 26, 2011 11:15 EDT
Just stopped by the NHLBI, the AIM-HIGH trial failed to establish the advantage of adding high-dose, extended-release niacin to statin treatment. AIM-HIGH sought to confirm previous smaller trials—and the hunch of many practitioners—but the surprising results underline the importance of randomized clinical trials. What have you learned from the AIM-HIGH trial?
Disclosure: I was a clinical investigator for AIM-HIGH